---
title: "Aiforia signs EUR 20 million venture debt with EIB"
url: "https://aibio.space/news/aiforia-signs-eur-20-million-venture-debt-eib/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-07-31"
section: "Debt Financing"
source: "https://www.inderes.fi/en/releases/aiforia-and-the-european-investment-bank-have-signed-an-agreement-for-eur-20-million-venture-debt-financing"
summary: "The binding agreement with the European Investment Bank has three tranches and covenants tied to management changes."
---

By the aibio.space news desk.

Sources

- [Aiforia Technologies Plc release (2026-07-31)](https://www.inderes.fi/en/releases/aiforia-and-the-european-investment-bank-have-signed-an-agreement-for-eur-20-million-venture-debt-financing)

2026-07-31

# Aiforia signs EUR 20 million venture debt with EIB

The binding agreement with the European Investment Bank has three tranches and covenants tied to management changes.

## Key facts

- **News type**: Debt Financing

- **Primary source**: [Aiforia Technologies Plc release (2026-07-31)](https://www.inderes.fi/en/releases/aiforia-and-the-european-investment-bank-have-signed-an-agreement-for-eur-20-million-venture-debt-financing)

*Glass office towers seen from below. CC0, via rawpixel. The picture shows the field, not the companies named.*

Aiforia Technologies Plc and the European Investment Bank (EIB) signed a binding venture debt financing agreement of up to EUR 20 million, according to the company's release dated July 31, 2026. The EIB is the lender under the agreement.

Aiforia announced on June 15, 2026, that it had agreed with the EIB on a non-binding indicative term sheet for a facility of up to EUR 20 million. The company says the main terms of the financing are in line with those previously announced.

The financing is divided into three tranches: EUR 5 million, EUR 7 million and EUR 8 million.

Because the financing is venture debt, its terms include non-financial covenants that the company describes as customary for such financings. For example, changes of the CEO or the chairperson of the Board require EIB's prior written consent. The release says this reflects the confidence EIB places in Aiforia's current management team.

The release names no placement agent or advisor.

[Report an error](https://aibio.space/reputation/#correction)

## More in Debt Financing

Debt Financing

### [Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J](https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/)

Oct 30, 2026

Debt Financing

### [Repligen announces $1.0 billion private convertible notes transaction](https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/)

Oct 30, 2026

Debt Financing

### [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

Oct 29, 2026

---
Source page: https://aibio.space/news/aiforia-signs-eur-20-million-venture-debt-eib/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Aiforia signs EUR 20 million venture debt with EIB", 2026-07-31, https://aibio.space/news/aiforia-signs-eur-20-million-venture-debt-eib/